EZHIP is a specific diagnostic biomarker for posterior fossa ependymomas, group PFA and diffuse midline gliomas H3-WT with EZHIP overexpression

Ítems similars

• DIPG-58. HISTONE H3 WILD-TYPE DIPG/DMG OVEREXPRESSING EZHIP EXTEND THE SPECTRUM OF DIFFUSE MIDLINE GLIOMAS WITH PRC2 INHIBITION BEYOND H3-K27M MUTATION
  per: Castel, David, et al.
  Publicat: (2020)
• The pediatric supratentorial MYCN-amplified high-grade gliomas methylation class presents the same radiological, histopathological and molecular features as their pontine counterparts
  per: A. Tauziède-Espariat, et al.
  Publicat: (2020-07-01)
• The pediatric supratentorial MYCN-amplified high-grade gliomas methylation class presents the same radiological, histopathological and molecular features as their pontine counterparts
  per: Tauziède-Espariat, A., et al.
  Publicat: (2020)
• Diagnostics of pediatric supratentorial RELA ependymomas: integration of information from histopathology, genetics, DNA methylation and imaging
  per: Pagès, Mélanie, et al.
  Publicat: (2018)
• Diffuse intrinsic pontine glioma-like tumor with EZHIP expression and molecular features of PFA ependymoma
  per: Pratt, Drew, et al.
  Publicat: (2020)